Data to Dose is the blueprint for drug discovery and clinical commercialization. Host Dr. Amos Ndhere, MD, MS, sits down with the industry executives, scientists and policymakers behind the high-stakes decisions that turn a target into a therapy. Episodes cover AI-driven discovery, PK/PD and first-in-human dosing, trial execution, regulatory strategy and launch. Built for pharma, biotech and CRO leaders who need the insight behind the headlines. Newsletter and show notes: datatodose.com. For educational purposes only - not medical, regulatory or investment advice. Views are the speakers' own.
15 Episodes



Don't miss an episode of “Data To Dose” and subscribe to it in the GetPodcast app.








